Discover Grünenthal

9/27/2024

Aachen, Germany, 27 September 2024 – Grünenthal announced today that Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Prior to his role as CSO he was Head of Strategy and Portfolio at Grünenthal.

7/17/2024

Aachen, Germany, 17 July 2024 – Grünenthal, a leading pharmaceutical company specializing in pain research and management, has announced significant investments in its Latin American production sites. These investments will enhance Grünenthal's production network, ensuring a reliable supply of medicines for patients across Latin America, Europe, and beyond.

Florian Dieckmann, Head Global Corporate Affairs & Communication

Florian Dieckmann

Head Global Corporate Affairs & Communication


Grünenthal GmbH

52099 Aachen


Phone +49 241 569 2555

E-Mail Florian.Dieckmann@grunenthal.com

Fabia Kehren, Head External Communications and Editorial Management

Fabia Kehren

Head of External Communication and Editorial Management


Grünenthal GmbH

52099 Aachen


Phone +49 241 569-3269

E-Mail Fabia.Kehren@grunenthal.com